Trial description:
International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia - Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination with Induction Chemotherapy
Contact name:
Dr Michael Gattens
Trial start date:
Monday, October 31, 2016
Trial end date:
Monday, November 1, 2021
Trial tumour type:
Haematological
Show on Radiotherapy:
No
